45 Group Health Research Institute 1730 Minor Ave, Suite 1600 — Seattle, Washington

45 Group Health Research Institute 1730 Minor Ave, Suite 1600 is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

45 Group Health Research Institute 1730 Minor Ave, Suite 1600 has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Meningitis.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 45 Group Health Research Institute 1730 Minor Ave, Suite 1600?

45 Group Health Research Institute 1730 Minor Ave, Suite 1600 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 45 Group Health Research Institute 1730 Minor Ave, Suite 1600 conducted?

45 Group Health Research Institute 1730 Minor Ave, Suite 1600 has 1 clinical trials on record. Their work covers Meningococcal Meningitis.

Is 45 Group Health Research Institute 1730 Minor Ave, Suite 1600 accredited by Crixeo Health?

45 Group Health Research Institute 1730 Minor Ave, Suite 1600 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 45 Group Health Research Institute 1730 Minor Ave, Suite 1600?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.